Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00097383 · COMPLETED
Trial details
- NCT number
- NCT00097383
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.